This report describes the global market size of Multiple Sclerosis Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
For the competitor segment, the report includes global key players of Multiple Sclerosis Drug as well as some small players.
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Multiple Sclerosis Drug as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment
- Beta interferons
- Glatiramer
- Cladribine
- Dimethyl fumarate
- Diroximel fumarate
- Fingolimod
- Monomethyl fumarate
- Ofatumumab
- Ozanimod
- Ponesimod
- Siponimod
- Others
Companies Covered
- Biogen Inc.
- Bristol Myers Squibb Co.
- EMD Serono Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Sanofi
- Teva Pharmaceuticals Industries LTD
- Roche
- Bayer
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Multiple Sclerosis Drug Market in North America (2019-2029)
Chapter 9 Historical and Forecast Multiple Sclerosis Drug Market in South America (2019-2029)
Chapter 10 Historical and Forecast Multiple Sclerosis Drug Market in Asia & Pacific (2019-2029)
Chapter 11 Historical and Forecast Multiple Sclerosis Drug Market in Europe (2019-2029)
Chapter 12 Historical and Forecast Multiple Sclerosis Drug Market in MEA (2019-2029)
Chapter 13 Summary For Global Multiple Sclerosis Drug Market (2019-2024)
Chapter 14 Global Multiple Sclerosis Drug Market Forecast (2024-2029)
Chapter 15 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- Biogen Inc.
- Bristol Myers Squibb Co.
- EMD Serono Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis AG
- Sanofi
- Teva Pharmaceuticals Industries LTD
- Roche
- Bayer